NIOSH’s role in EEOICPA is an important one because they do the workers’ dose reconstructions. In 2002 Congress published Guidelines for Determining the Probability of Causation under EEOICPA.
Special Exposure Cohorts
One of the provisions under EEOICPA is for Special Exposure Cohorts (SEC). NIOSH’s SEC webpage discusses how to file an SEC.
NIOSH Reports on Facility Contamination
- Report on Residual Radioactive and Beryllium Contamination at Atomic Weapons Employer Facilities and Beryllium Vendor Facilities, 2006
- Appendix A-1 Residual Radioactive Contamination Summary of All Sites as of March 2, 2011
- Appendix A-3 Residual Radioactivity Evaluations for Individual Facilities
- Appendix B-1 Residual Beryllium Contamination Summary of All Sites as of March 3, 2011
- Appendix B-3 Residual Beryllium Evaluations for Individual Facilities
NIOSH EEOICPA Videos
- NIOSH: Ombudsman to NIOSH for EEOICPA Part B–Denise Brock
- NIOSH: Role in EEOICPA Part B–Stuart Hinnefeld
New NIOSH FOIA
This email stream was obtained under the Freedom of Information Act. The emails discuss how NIOSH should prioritize Special Exposure Cohort petitions.
NIOSH FOIA Fee Waiver
NIOSH has issued a blanket fee waiver for all requesters who act as advocates of former nuclear workers.
A Critique of NIOSH’s Dose Reconstruction Methodology
- Material Errors, Questions, Concerns, Objections, False and Misleading Statements, Omissions, Gaps, Factual Mistakes, in NIOSH assigned share estimate, NIOSH models, NIOSH Process and Procedures and NIOSH documentation used for Rejection of Compensation Under EEOICPA for Claimant for Cancers caused by Plutonium Radiation Exposure at Rocky Flats
November 2012 NIOSH Ombudsman’s Workshop
The purpose of this EEOICPA Workshop was to give advocates an opportunity to observe multi-agency representatives giving in-depth instruction and guidance on program nuances such as dose reconstruction, special exposure cohort process, site exposure matrices, home health, and other relevant issues.
The workshop was also a great opportunity for advocates to meet and network with each other as well as interact with agency representatives. It was an educational and fun rather than an adversarial or confrontational experience for the advocates who are much needed in the EEOICPA process. Below you will find PowerPoints and videos made at the workshop to assist advocates and claimants better understand how EEOICPA works to help all valid EEOICPA claims get paid.
At the workshop, a question was raised on how to know which cancers had a larger chance of being compensable. NIOSH responded that internal exposures often resulted in larger organ doses than external exposures, and that different radionuclides concentrate in different organs. The probability of causation depends on the cancer. NIOSH was asked where someone can find information about what materials concentrate in what organs, and replied that information is contained in a number of ICRP reports, and promised to send the numbers of those reports. NIOSH warned that ICRP sells the reports and that they are expensive. NIOSH has provided the ICRP reports that describe how radioactive materials behave in the body are given in the following message. Be sure to read the introductory sentences, because they identify reports that are not in the table.
- Lung model is used for all elements and it is ICRP 66
- GI tract model is used for all elements and it is ICRP 30
- There is a different biokinetic model for each element and that model is attached to the lung and GI tract models to model the intakes.
- Various reports describe the biokinetic models for various elements (see table below). For those that are not listed, the model in ICRP 30 is used. (The table is on page 9 of IG-2).
The following web link to IG-002 that is posted on the DCAS website. It provides a general description of the lung and GI model, as well as some basic concepts on how we go about DRs: http://www.cdc.gov/niosh/ocas/pdfs/dr/drgdin.pdf.
- Dr. Michael McCawley: Preventing Beryllium Disease
- DOL Presentation
- Dose Reconstruction Process Overview
- Addition of Chronic Lymphocytic Leukemia to EEOICPA Covered Conditions
- SEC Petitions: Qualifying Basis, Evaluation Process, and Examples
- DOE Presentation
- Worker Health Protection Program and Early Lung Cancer Detection
- What You can do to Assist the Claimant
- Cold War Patriots
- Professional Case Management
- Gateway to the Atomic Age
Dose Reconstruction Power Points
NIOSH has held several workshops explaining how they do their dose reconstructions. Here are three PowerPoint presentations from their September 22-23, 2009 workshop.
Dose Reconstruction Process Overview shows how NIOSH handles a claim from the beginning when they receive a claimant’s information from DOL through the dose reconstruction process.
Dose Reconstruction Examples illustrates an overestimate, an underestimate, best estimate and a partial estimate based on hypothetical claims.
Probability of Causation and NIOSH-IREP discusses how NIOSH uses the IREP as well as the reasoning and statistics it uses.
Validity of X-Ray reports
Recently there has been some confusion within EEOICPA on whether certain x-ray reports are valid or not. Some claimants have had their “b-reads” refused if the technician did not sign the report. NIOSH’s Dr. Howard clarified the issue for ANWAG. If you have had this problem, please contact ANWAG or EECAP for help.